Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07697950

NIBP Accuracy Study for Adult Subject Populations

The purpose of this study is to collect NIBP and invasive aortic pressure data from the clinical setting.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

About this study

The purpose of the study is to collect clinical data for validation of the accuracy of non-invasive blood pressure (NIBP) measurement algorithms on the Non-invasive Blood Pressure (NIBP) Standard Parameter Module (SPM) per IEC 80601-2-30:2018, Medical electrical equipment-Part 2-30: Particular requirements for basic safety and essential performance of automated non-invasive sphygmomanometers standard, section 201.106. In addition, the study will be conducted per ISO 81060-2:2018+AMD2:2024 Non-invasive sphygmomanometers-Part 2: Clinical investigation of intermittent automated measurement type.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age requirement: 18 and over.
  • Have an upper limb (right OR left side) that fits the cuff size of the device (circumference ranging 17 cm to 40 cm) OR have a thigh (right OR left side) that fits a cuff size of the device (circumference ranging 38 to 50 cm).
  • Have an arterial line as a standard of care, which measures blood pressure at the aortic root.
  • Able to provide written informed consent.
  • Expected to remain in the unit for the duration of the study procedure.

Exclusion criteria

  • Have previously participated in this study (no subject may participate more than once).
  • Pregnant and lactating women per site standard of care.
  • Subjects with peripheral arterial diseases (causing left/right arm difference)
  • Hemodynamically unstable subjects at the discretion of the investigator.
  • Exhibited injuries, deformities, intravenous lines, or other abnormalities that, in the opinion of the Investigator, may prevent proper cuff application or functioning.
  • Are suffering from infection(s) or immunocompromised patients that require isolation.
  • PI or designee decision due to subject health conditions

Treatment and study plan

NIBP Measurement

Device

The collection of non-invasive blood pressure measurements using NIBP Standard Parameter Module with SuperSTAT algorithm with simultaneous invasive blood pressure waveform recordings per discretion of the sponsor upon combining the data from other clinical studies to comply with ISO 81060-2:2018 +AMD2:2024.

Primary outcomes

  1. Primary Outcome Measure

    Time frame: Up to 2 hours after time of enrollment

    Collection of non-invasive blood pressure measurements data from subjects in clinical setting.

Other outcomes

  1. Incidence of Safety Events

    Time frame: 24 months

    Analysis of adverse events will be listed per subject, summarized with counts and percentages of events, and summarized with counts and percentages of subjects with events.

Study contacts

Contact information is provided by the study sponsor or research team.

Pasi Karjalainen

CONTACT

[email protected]

+ 358 40 5480853

Sponsors and collaborators

Lead sponsor

GE Healthcare

Industry

Registry information

Official study title

Non-Invasive Blood Pressure Accuracy Study for Adult Subject Populations

Important dates

Study start
2025
Primary completion
2026
Study completion
2027
First posted
Jul 13, 2026
Registry last updated
Jul 13, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.